Lake Jackson, TX, United States of America

Jason Rogers

This inventor holds 1 USPTO granted patent. Top assignees: Monopar Therapeutics, Inc., Northstar Medical Technologies, LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jason Rogers. Retrieved from https://idiyas.com/inventor/jason-rogers-6nyjodxn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jason Rogers - Innovator in Radiopharmaceuticals

Introduction

Jason Rogers is a notable inventor based in Lake Jackson, TX (US). He has made significant contributions to the field of radiopharmaceuticals, particularly with his innovative work on targeted therapies. His dedication to advancing medical science is evident through his patent and collaborations with leading companies in the industry.

Latest Patents

Jason holds a patent for the "Urokinase Plasminogen Activator Receptor-Targeted Radiopharmaceutical." This invention represents a significant advancement in targeted cancer therapies, aiming to improve treatment efficacy and patient outcomes. He has 1 patent to his name, showcasing his innovative approach to medical technology.

Career Highlights

Throughout his career, Jason has worked with prominent companies such as Northstar Medical Technologies, LLC and Monopar Therapeutics, Inc. His experience in these organizations has allowed him to develop and refine his expertise in radiopharmaceuticals, contributing to the advancement of medical treatments.

Collaborations

Jason has collaborated with esteemed professionals in his field, including Andrew Mazar and James T. Harvey. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, Jason Rogers is a dedicated inventor whose work in radiopharmaceuticals has the potential to transform cancer treatment. His innovative spirit and collaborative efforts continue to drive advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…